1. |
Speich B, von Niederhäusern B, Schur N, et al. Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data. J Clin Epidemiol, 2018, 96: 1-11.
|
2. |
Roundtable on Value and Science-Driven Health Care, Forum on Drug Discovery Development, and Translation, Board on Health Sciences Policy, et al. Large simple trials and knowledge generation in a learning health system: workshop summary. Washington DC: National Academies Press, 2013.
|
3. |
Roehr B. The appeal of large simple trials. BMJ, 2013, 346: f1317.
|
4. |
Foulkes MA. Large simple trials. Wiley StatsRef: Statistics Reference Online, 2014.
|
5. |
Peto R, Collins R, Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol, 1995, 48(1): 23-40.
|
6. |
Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials. Stat Med, 1984, 3(4): 409-422.
|
7. |
Whiteley WN, Anand S, Bangdiwala SI, et al. Are large simple trials for dementia prevention possible. Age Ageing, 2020, 49(2): 154-160.
|
8. |
FDA. Oversight of clinical investigations—a risk-based approach to monitoring. 2013.
|
9. |
FDA. Guidance for industry: determining the extent of safety data collection needed in late stage premarket and postapproval clinical investigations (draft guidance). 2013.
|
10. |
FDA. Guidance for industry and investigators: safety reporting requirements for INDs and BA/BE studies. 2013.
|
11. |
Baciu A, Stratton K, Burke SP. The future of drug safety. Washington DC: National Academies Press, 2007.
|
12. |
Reynolds RF, Lem JA, Gatto NM, et al. Is the large simple trial design used for comparative, post-approval safety research. A review of a clinical trials registry and the published literature. Drug Saf, 2011, 34(10): 799-820.
|
13. |
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58, 050 patients with suspected acute myocardial infarction. Lancet, 1995, 345: 669-685.
|
14. |
Baumfeld Andre E, Reynolds R, Caubel P, et al. Trial designs using real-world data: the changing landscape of the regulatory approval process. Pharmacoepidemiol Drug Saf, 2020, 29(10): 1201-1212.
|
15. |
Hasford J. Large simple double-blind randomized trials for the rapid assessment of the effectiveness of COVID-19 vaccines. J Infect Dis, 2020, 222(9): 1571-1572.
|
16. |
Excler JL, Saville M, Berkley S, et al. Vaccine development for emerging infectious diseases. Nat Med, 2021, 27(4): 591-600.
|
17. |
Eapen ZJ, Lauer MS, Temple RJ. The imperative of overcoming barriers to the conduct of large, simple trials. JAMA, 2014, 311(14): 1397-1398.
|
18. |
Collins R, Bowman L, Landray M, et al. The magic of randomization versus the myth of real-world evidence. N Engl J Med, 2020, 382(7): 674-678.
|
19. |
Harrington DP, Baden LR, Hogan JW. A large, simple trial leading to complex questions. N Engl J Med, 2021, 384(6): 576-577.
|
20. |
van Staa TP, Klungel O, Smeeth L. Use of electronic healthcare records in large-scale simple randomized trials at the point of care for the documentation of value-based medicine. J Intern Med, 2014, 275(6): 562-569.
|
21. |
王雯, 高培, 吴晶, 等. 构建基于既有健康医疗数据的研究型数据库技术规范. 中国循证医学杂志, 2019, 19(7): 763-770.
|
22. |
Health Nio. Clinical research and the HIPAA privacy rule. 2004.
|
23. |
European Data Protection Board. Question and answers on the interplay between the clinical trials regulation and thegeneral data protection regulation. 2014.
|
24. |
国务院. 中华人民共和国人类遗传资源管理条例. 2019.
|
25. |
Price WN, Cohen IG. Privacy in the age of medical big data. Nat Med, 2019, 25(1): 37-43.
|
26. |
Legislation. Data protection act 2018. 2018.
|
27. |
全国人民代表大会常务委员会. 中华人民共和国个人信息保护法. 2021.
|
28. |
Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med, 2021, 384(8): 693-704.
|
29. |
The Diabetes Prevention Program Research Group. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care, 1999, 22(4): 623-634.
|
30. |
Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol, 2015, 3(11): 866-875.
|
31. |
Medicine Io. Large simple trials and knowledge generation in a learning health system: workshop summary. Washington DC: National Academies Press, 2013.
|
32. |
Califf RM. Large simple trials: really, it can't be that simple! Eur Heart J, 2014, 35(9): 549-551.
|
33. |
国家药品监督管理局. 真实世界证据支持药物研发与审评的指导原则(试行). 2020.
|
34. |
国家药品监督管理局. 真实世界研究支持儿童药物研发与审评的技术指导原则(试行). 2020.
|
35. |
国家药品监督管理局. 真实世界数据用于医疗器械临床评价技术指导原则(试行). 2020.
|
36. |
World Health Origanization. Global strategyon digital health 2020-2025. 2021.
|